Lehmann M - Search Results

1

Corrigendum to "Biochemical, cellular and structural characterization of novel and selective ERK3 inhibitors" [Bioorg. Med. Chem. Lett. 30 (2020) 127551].

Grädler U, Busch M, Leuthner B, Raba M, Burgdorf L, Lehmann M, Linde N, Esdar C. Grädler U, et al. Among authors: lehmann m. Bioorg Med Chem Lett. 2021 Oct 1;49:128262. doi: 10.1016/j.bmcl.2021.128262. Epub 2021 Aug 2. Bioorg Med Chem Lett. 2021. PMID: 34352662 No abstract available.

2

Biochemical, cellular and structural characterization of novel and selective ERK3 inhibitors.

Grädler U, Busch M, Leuthner B, Raba M, Burgdorf L, Lehmann M, Linde N, Esdar C. Grädler U, et al. Among authors: lehmann m. Bioorg Med Chem Lett. 2020 Nov 15;30(22):127551. doi: 10.1016/j.bmcl.2020.127551. Epub 2020 Sep 11. Bioorg Med Chem Lett. 2020. PMID: 32927028

3

Fragment-based discovery of focal adhesion kinase inhibitors.

Grädler U, Bomke J, Musil D, Dresing V, Lehmann M, Hölzemann G, Greiner H, Esdar C, Krier M, Heinrich T. Grädler U, et al. Among authors: lehmann m. Bioorg Med Chem Lett. 2013 Oct 1;23(19):5401-9. doi: 10.1016/j.bmcl.2013.07.050. Epub 2013 Jul 31. Bioorg Med Chem Lett. 2013. PMID: 23973211

4

Discovery and Optimization of 2-Arylquinazolin-4-ones into a Potent and Selective Tankyrase Inhibitor Modulating Wnt Pathway Activity.

Buchstaller HP, Anlauf U, Dorsch D, Kuhn D, Lehmann M, Leuthner B, Musil D, Radtki D, Ritzert C, Rohdich F, Schneider R, Esdar C. Buchstaller HP, et al. Among authors: lehmann m. J Med Chem. 2019 Sep 12;62(17):7897-7909. doi: 10.1021/acs.jmedchem.9b00656. Epub 2019 Aug 20. J Med Chem. 2019. PMID: 31381853

5

Optimization of a Screening Hit toward M2912, an Oral Tankyrase Inhibitor with Antitumor Activity in Colorectal Cancer Models.

Buchstaller HP, Anlauf U, Dorsch D, Kögler S, Kuhn D, Lehmann M, Leuthner B, Lodholz S, Musil D, Radtki D, Rettig C, Ritzert C, Rohdich F, Schneider R, Wegener A, Weigt S, Wilkinson K, Esdar C. Buchstaller HP, et al. Among authors: lehmann m. J Med Chem. 2021 Jul 22;64(14):10371-10392. doi: 10.1021/acs.jmedchem.1c00800. Epub 2021 Jul 13. J Med Chem. 2021. PMID: 34255518

6

Discovery and Structure-Based Optimization of Next-Generation Reversible Methionine Aminopeptidase-2 (MetAP-2) Inhibitors.

Heinrich T, Seenisamy J, Blume B, Bomke J, Calderini M, Eckert U, Friese-Hamim M, Kohl R, Lehmann M, Leuthner B, Musil D, Rohdich F, Zenke FT. Heinrich T, et al. Among authors: lehmann m. J Med Chem. 2019 May 23;62(10):5025-5039. doi: 10.1021/acs.jmedchem.9b00041. Epub 2019 May 2. J Med Chem. 2019. PMID: 30939017

7

[Physiological and pathophysiological changes of the ageing lung].

Johnsen M, Lehmann M. Johnsen M, et al. Among authors: lehmann m. Z Gerontol Geriatr. 2025 Jan 20. doi: 10.1007/s00391-024-02401-5. Online ahead of print. Z Gerontol Geriatr. 2025. PMID: 39833352 Review. German.

8

Effect of Surface Finishing and Nitriding on the Wetting Properties of Hot Forging Tools.

Kapuściński J, Macyszyn Ł, Zielinski M, Meller A, Lehmann M, Bartkowiak T. Kapuściński J, et al. Among authors: lehmann m. Materials (Basel). 2025 Jan 3;18(1):172. doi: 10.3390/ma18010172. Materials (Basel). 2025. PMID: 39795816 Free PMC article.

9

[Platelet Concentrates - Indication, Informed Consent, Transfusion and Adverse Events].

Müller MM, Lehmann M, Neef V, Zacharowski K, Tonn T. Müller MM, et al. Among authors: lehmann m. Anasthesiol Intensivmed Notfallmed Schmerzther. 2025 Jan;60(1):35-51. doi: 10.1055/a-2234-1341. Epub 2025 Jan 8. Anasthesiol Intensivmed Notfallmed Schmerzther. 2025. PMID: 39778586 Review. German.

10

Early Restrictive vs Liberal Oxygen for Trauma Patients: The TRAUMOX2 Randomized Clinical Trial.

Arleth T, Baekgaard J, Siersma V, Creutzburg A, Dinesen F, Rosenkrantz O, Heiberg J, Isbye D, Mikkelsen S, Hansen PM, Zwisler ST, Darling S, Petersen LB, Mørkeberg MCR, Andersen M, Fenger-Eriksen C, Bach PT, Van Vledder MG, Van Lieshout EMM, Ottenhof NA, Maissan IM, Den Hartog D, Hautz WE, Jakob DA, Iten M, Haenggi M, Albrecht R, Hinkelbein J, Klimek M, Rasmussen LS, Steinmetz J; TRAUMOX2 Trial Group. Arleth T, et al. JAMA. 2024 Dec 10. doi: 10.1001/jama.2024.25786. Online ahead of print. JAMA. 2024. PMID: 39657224

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

1,642 results

Search Page

Filters